Complete Up To Date Information about BMD / Stenorol .
NADA Number: 140-919 | |
| Proprietary Name |
BMD® / Stenorol® |
|---|---|
| Sponsor |
Huvepharma AD |
| Sponsor Address |
33 James Boucher Blvd. Sophia 1407, Bulgaria |
| Ingredients |
Halofuginone Hydrobromide Bacitracin Methylene Disalicylate |
| Species |
Turkey, growing |
| Routes of Administration |
Per Os |
| Dose Form |
Medicated feed |
| Drug Form |
Type A Medicated Article |
| Dispensing Status |
OTC |
| Exclusivity |
Granted for the prevention of coccidiosis and increased weight gain in turkeys. |
| Withdrawal Time |
Growing Turkey: 7 days before slaughter. |
|
Dosage Amount, Indications & Limitations |
558.265 Halofuginone hydrobromide. Specifications: Halofuginone hydrobromide Type A medicated article (2.72 grams per pound) and bacitracin methylene disalicylate Type A medicated article (30, 50, or 60 grams per pound) to make Type C medicated feeds containing 1.36 to 2.72 grams per ton halofuginone hydrobromide and 10 to 50 grams per ton bacitracin methylene disalicylate. The use of halofuginone hydrobromide and bacitracin methylene disalicylate Type A medicated articles to make Type C medicated turkey feeds requires an approved form FDA 1900. Conditions of use: Turkeys (growing) Amount: 1.36 to 2.72 grams per ton of feed halofuginone hydrobromide and 10 to 50 grams per ton of feed bacitracin methylene disalicylate. Indications: For prevention of coccidiosis caused by E. adenoeides, E. meleagrimitis, and E. gallopavonis, and for increase rate of weight gain. Limitations: Feed continuously as sole rations. Withdraw 7 days before slaughter. Do not feed to laying chickens or water fowl. Keep out of lakes, ponds, and streams. Halofuginone is toxic to fish and aquatic life. Halofuginone is an irritant to eyes and skin. Avoid contact with skin, eyes, or clothing. |
| Tolerances |
The marker residue selected to monitor for total residues of halofuginone hydrobromide in broilers and turkeys is parent halofuginone hydrobromide and the target tissue selected is liver. A tolerance is established in broilers of 0.16 part per million and in turkeys of 0.13 part per million for parent halofuginone hydrobromide in liver. These marker residue concentrations in liver correspond to total residue concentrations of 0.3 part per million in liver. The tolerance for residues of bacitracin from zinc bacitracin or bacitracin methylene disalicylate in uncooked edible tissues of cattle, swine, chickens, turkeys, pheasants, and quail, and in milk and eggs is 0.5 part per million |